Trialect

Active

Transformational Impact Awards

Prostate Cancer UK

Our Transformational Impact Awards support large-scale research investments covering high-quality discovery science, through to translational and clinical research. These awards will deliver research which cannot be achieved through our other funding schemes (namely our Research Innovation Awards), with the ambition to significantly expand our understanding of the disease, maximise the scale and speed of progress in prostate cancer research and crucially deliver a positive impact on the lives of men with prostate cancer. This may be by:

directly delivering evidence that leads to practice change and patient benefit;
significantly accelerating the progression towards that patient benefit;
delivering a transformational step change in our understanding of the disease

Specialties

Cancer

Drug Development

Clinical Trials

Oncology

Eligibility Requirements

This scheme is designed to support individual clinical studies, as well as programmes of research (preclinical, clinical or a combination) consisting of highly interconnected workstreams that offer added benefit when delivered collectively. Smaller-scale proposals for more focused, stand-alone research projects will be more suited to our Research Innovation Awards.

Sponsor Details

Sponsor Institute/Organizations: Prostate Cancer UK

Address: Fourth Floor, The Counting House, 53 Tooley Street, London, SE1 2QN

View Funding Opportunity

Grant

Letter Of Intent Deadline:

Sep 25, 2024

Final Deadline:

Sep 25, 2024

Funding Amount:

$1,500,000

3 awards available. We anticipate that proposals will be around £1.5m in value and up to 5 years in duration. Proposals up to the value of £2m will still be accepted, however if you wish to apply for more than £1.5m you must discuss your study with us in advance of the submission deadline. Proposals under £750k are likely to be better suited to our Research Innovation Awards scheme.